Clinical Trials Directory

Trials / Unknown

UnknownNCT02756442

Respiratory Disorder During Sleep in the Pregnancy : A Risk Factor in Gestational Diabetese

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Introduction: The pregnancy brings about physiological and hormonal modifications which cause sleep disorder. The sleeplessness, snoring and a bad sleepquality are frequent during the pregnancy. Also a limited breathing airflow happens very often during the pregnancy. The limited airflow causes micro-awakenings that enter in the frame of the high resistances airways syndrome. To our knowledge there is no study about the outcome of micro-awakenings at pregnant women. Objectives: To compare the prevalence of the high resistances airways syndrome (RERA) in pregnant woman with or without gestational diabetes Methods : It is a monocentrical prospective study at pregnant women after the 30th amenorrhea week who consul the gynecologie and obstetrics department of the CHU NORD in Marseille. We are going to compare the breathing disorder during sleep of a control group with a group of women with gestational diabetes. A polysomnograph will be run at the included patients' home. Expected results : The physiological and hormonal modifications during the pregnancy could favor nocturnal sleep events (snoring, SAHOS and RERA) and its complications as gravidic HPN And gestational diabetes cause maternal and fœtal and morbidity and mortality. We put the hypothesis that limited airflow in association with micro-awakenings in the RERA have a negative impact on the glucose metabolism and favor the gestational diabetes.

Conditions

Interventions

TypeNameDescription
OTHERRespiratory disorder assessment during sleep

Timeline

Start date
2016-04-01
Primary completion
2018-04-01
Completion
2019-04-01
First posted
2016-04-29
Last updated
2016-04-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02756442. Inclusion in this directory is not an endorsement.